IBio, Historical Financial Ratios
| IBIO Stock | USD 5.54 0.06 1.07% |
IBio, Common is lately reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.39 or Days Sales Outstanding of 1.1 K will help investors to properly organize and evaluate iBio, Common Stock financial condition quickly.
IBio, |
About IBio, Financial Ratios Analysis
iBio, Common StockFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate IBio, Common investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on IBio, financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across IBio, Common history.
IBio, Common Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing iBio, Common Stock stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on IBio, Common sales, a figure that is much harder to manipulate than other iBio, Common Stock multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is iBio, Common Stock dividend as a percentage of IBio, Common stock price. iBio, Common Stock dividend yield is a measure of IBio, Common stock productivity, which can be interpreted as interest rate earned on an IBio, Common investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from IBio, Common's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into iBio, Common Stock current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iBio, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, IBio, Common's Average Inventory is very stable compared to the past year. As of the 11th of March 2025, Research And Ddevelopement To Revenue is likely to grow to 21.78, while Price To Sales Ratio is likely to drop 37.39.
| 2024 | 2025 (projected) | Dividend Yield | 0.0372 | 0.033 | Price To Sales Ratio | 39.36 | 37.39 |
IBio, Common fundamentals Correlations
Click cells to compare fundamentals
IBio, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
IBio, Common fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 318.36 | 249.17 | 47.58 | 34.22 | 39.36 | 37.39 | |
| Ptb Ratio | 5.44 | 1.79 | 0.97 | 0.36 | 0.42 | 0.39 | |
| Days Sales Outstanding | 1.3K | 850.69 | 934.33 | 1.2K | 1.0K | 1.1K | |
| Book Value Per Share | 138.75 | 72.8 | 12.56 | 5.57 | 5.01 | 4.76 | |
| Free Cash Flow Yield | (0.0596) | (0.43) | (2.42) | (2.44) | (2.8) | (2.66) | |
| Operating Cash Flow Per Share | (38.42) | (42.98) | (24.86) | (4.84) | (5.57) | (5.85) | |
| Stock Based Compensation To Revenue | 0.24 | 0.67 | 1.84 | 9.06 | 8.15 | 8.56 | |
| Capex To Depreciation | 2.14 | 3.07 | 4.16 | 0.17 | 0.19 | 0.18 | |
| Pb Ratio | 5.44 | 1.79 | 0.97 | 0.36 | 0.42 | 0.39 | |
| Ev To Sales | 304.8 | 230.33 | 49.72 | (9.11) | (10.48) | (9.95) | |
| Free Cash Flow Per Share | (45.02) | (56.31) | (29.54) | (4.9) | (5.63) | (5.91) | |
| Roic | (0.18) | (0.22) | (0.55) | (0.83) | (0.58) | (0.61) | |
| Net Income Per Share | (29.72) | (58.49) | (23.94) | (6.5) | (7.48) | (7.85) | |
| Sales General And Administrative To Revenue | 7.59 | 9.29 | 14.32 | 51.88 | 46.7 | 49.03 | |
| Research And Ddevelopement To Revenue | 1.96 | 4.21 | 7.44 | 23.04 | 20.74 | 21.78 | |
| Capex To Revenue | 0.7 | 2.18 | 4.88 | 0.93 | 0.84 | 1.02 | |
| Cash Per Share | 123.93 | 38.44 | 3.51 | 3.71 | 3.34 | 3.17 | |
| Pocfratio | (19.65) | (3.02) | (0.49) | (0.42) | (0.37) | (0.39) | |
| Interest Coverage | (5.68) | (12.68) | (35.19) | (96.71) | (87.04) | (91.39) | |
| Capex To Operating Cash Flow | (0.17) | (0.31) | (0.19) | (0.0113) | (0.0102) | (0.0107) | |
| Pfcf Ratio | (35.97) | (16.77) | (2.31) | (0.41) | (0.37) | (0.39) | |
| Income Quality | 1.3 | 0.75 | 0.47 | 0.74 | 0.67 | 0.62 | |
| Roe | (0.21) | (0.8) | (1.91) | (1.17) | (1.05) | (1.1) | |
| Ev To Operating Cash Flow | (18.16) | (3.16) | (0.91) | 0.11 | 0.0994 | 0.1 | |
| Pe Ratio | (25.4) | (2.22) | (0.51) | (0.31) | (0.28) | (0.29) | |
| Ev To Free Cash Flow | (15.5) | (2.41) | (0.77) | 0.11 | 0.0983 | 0.1 | |
| Earnings Yield | (0.0394) | (0.45) | (1.96) | (3.23) | (3.72) | (3.53) | |
| Intangibles To Total Assets | 0.0121 | 0.006478 | 0.0488 | 0.13 | 0.21 | 0.34 | |
| Net Debt To E B I T D A | 2.44 | (0.2) | (0.45) | 0.7 | 0.63 | 0.66 | |
| Current Ratio | 15.74 | 1.48 | 1.22 | 4.08 | 3.67 | 3.7 | |
| Tangible Book Value Per Share | 137.53 | 67.23 | 8.16 | 4.16 | 3.75 | 3.56 | |
| Receivables Turnover | 0.29 | 0.43 | 0.39 | 0.32 | 0.36 | 0.34 | |
| Shareholders Equity Per Share | 138.77 | 72.8 | 12.56 | 5.57 | 5.01 | 4.76 |
Pair Trading with IBio, Common
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IBio, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBio, Common will appreciate offsetting losses from the drop in the long position's value.Moving against IBio, Stock
| 0.8 | MNOV | MediciNova | PairCorr |
| 0.77 | NKTX | Nkarta Inc | PairCorr |
| 0.76 | IMMX | Immix Biopharma | PairCorr |
| 0.75 | PALI | Palisade Bio | PairCorr |
| 0.73 | MLTX | MoonLake Immunotherapeuti | PairCorr |
The ability to find closely correlated positions to IBio, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IBio, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IBio, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iBio, Common Stock to buy it.
The correlation of IBio, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IBio, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iBio, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IBio, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iBio, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IBio, Common. If investors know IBio, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IBio, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share | Quarterly Revenue Growth (0.88) | Return On Assets | Return On Equity |
The market value of iBio, Common Stock is measured differently than its book value, which is the value of IBio, that is recorded on the company's balance sheet. Investors also form their own opinion of IBio, Common's value that differs from its market value or its book value, called intrinsic value, which is IBio, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IBio, Common's market value can be influenced by many factors that don't directly affect IBio, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IBio, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBio, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBio, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.